FDA warns on safety threat posed by 2 drugs initially backed by Trump for Covid-19 — following an emergency use authorization

Two of President Trump’s initial top picks as near-term therapeutic remedies for Covid-19 are the subject of an FDA safety warning today.

The agency issued an alert on Friday on hydroxychloroquine and chloroquine for “serious and potentially life-threatening heart rhythm problems, that have been reported with their use for the treatment or prevention of COVID-19.”